Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study

被引：44

作者：

Campa, Daniele ^{[1
]}

Matarazzi, Martina ^{[1
,2
]}

Greenhalf, William ^{[3
]}

Bijlsma, Maarten ^{[4
]}

Saum, Kai-Uwe ^{[5
]}

Pasquali, Claudio ^{[6
]}

van Laarhoven, Hanneke ^{[4
]}

Szentesi, Andrea ^{[7
,8
]}

Federici, Francesca ^{[9
]}

Vodicka, Pavel ^{[10
,11
,12
]}

Funel, Niccola ^{[13
]}

Pezzilli, Raffaele ^{[14
]}

Bueno-de-Mesquita, H. Bas ^{[15
,16
,17
,18
]}

Vodickova, Ludmila ^{[10
,11
,12
]}

Basso, Daniela ^{[19
]}

Obazee, Ofure ^{[2
]}

Hackert, Thilo ^{[20
]}

Soucek, Pavel ^{[12
]}

Cuk, Katarina ^{[5
]}

Kaiser, Joerg ^{[20
]}

Sperti, Cosimo ^{[23
]}

Lovecek, Martin ^{[21
,22
]}

Capurso, Gabriele ^{[24
,25
]}

Mohelnikova-Duchonova, Beatrice ^{[26
]}

Khaw, Kay-Tee ^{[27
]}

Koenig, Anna-Katharina ^{[20
]}

Kupcinskas, Juozas ^{[28
]}

Kaaks, Rudolf ^{[29
]}

Bambi, Franco ^{[30
]}

Archibugi, Livia ^{[24
,25
]}

Mambrini, Andrea ^{[9
]}

Cavestro, Giulia Martina ^{[31
]}

Landi, Stefano ^{[1
]}

Hegyi, Peter ^{[7
,8
,32
]}

Izbicki, Jakob R. ^{[33
]}

Gioffreda, Domenica ^{[34
,35
]}

Zambon, Carlo Federico ^{[23
]}

Tavano, Francesca ^{[34
,35
]}

Talar-Wojnarowska, Renata ^{[36
]}

Jamroziak, Krzysztof ^{[37
]}

Key, Timothy J. ^{[38
]}

Delle Fave, Gianfranco ^{[24
]}

Strobel, Oliver ^{[20
]}

Jonaitis, Laimas ^{[28
]}

Andriulli, Angelo ^{[34
,35
]}

Lawlor, Rita T. ^{[39
]}

Pirozzi, Felice ^{[40
]}

Katzke, Verena ^{[29
]}

Valsuani, Chiara ^{[9
]}

Vashist, Yogesh K. ^{[33
]}

机构：

[1] Univ Pisa, Dept Biol, Pisa, Italy

[2] German Canc Res Ctr, Genom Epidemiol Grp, Neuenheimer Feld 280, D-69120 Heidelberg, Germany

[3] Univ Liverpool, Liverpool Pancreas Biomed Res Unit, Inst Hlth Res, Liverpool, Merseyside, England

[4] Acad Med Ctr, Med Oncol, Amsterdam, Netherlands

[5] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany

[6] Univ Padua, Dept Surg Oncol & Gastroenterol DiSCOG, Pancreat & Digest Endocrine Surg, Padua, Italy

[7] Univ Pecs, Inst Translat Med, Pecs, Hungary

[8] Univ Szeged, Dept Med 1, Szeged, Hungary

[9] Azienda USL Toscana Nord Ovest, Oncol Unit Massa Carrara, Oncol Dept, Carrara, Italy

[10] Acad Sci Czech Republ, Inst Expt Med, Dept Mol Biol Canc, Prague, Czech Republic

[11] Charles Univ Prague, Med Fac 1, Inst Biol & Med Genet, Prague, Czech Republic

[12] Charles Univ Prague, Fac Med Pilsen, Biomed Ctr, Plzen, Czech Republic

[13] Univ Pisa, Unit Expt Surg Pathol, Dept Surg, Pisa, Italy

[14] St Orsola Malpighi Hosp, Dept Digest Syst, Pancreas Unit, Bologna, Italy

[15] Natl Inst Publ Hlth & Environm RIVM, Dept Determinants Chron Dis DCD, Bilthoven, Netherlands

[16] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands

[17] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England

[18] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia

[19] Univ Hosp Padova, Dept Lab Med, Padua, Italy

[20] Univ Hosp Heidelberg, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany

[21] Palacky Univ Olomouc, Fac Med & Dent, Dept Surg 1, Olomouc, Czech Republic

[22] Univ Hosp Olomouc, Olomouc, Czech Republic

[23] Univ Padua, Surg Clin Dept Surg 3, Dept Surg Oncol & Gastroenterol DiSCOG, Padua, Italy

[24] Sapienza Univ, S Andrea Hosp, Digest & Liver Dis Unit, Rome, Italy

[25] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst, Pancreas Translat & Clin Res Ctr, PancreatoBiliary Endoscopy & EUS Div, Milan, Italy

[26] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Dept Oncol, Olomouc, Czech Republic

[27] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Clin Gerontol Unit, Cambridge, England

[28] Lithuanian Univ Hlth Sci, Dept Gastroenterol, Kaunas, Lithuania

[29] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

[30] Azienda Osped Univ Meyer, Blood Transfus Serv, Florence, Italy

[31] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Gastroenterol & Gastrointestinal Endoscopy Unit, Milan, Italy

[32] MTA SZTE Momentum Translat Gastroenterol Res Grp, Szeged, Hungary

[33] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany

[34] IRCCS Osped Casa Sollievo Sofferenza, Div Gastroenterol, San Giovanni Rotondo, Italy

[35] IRCCS Osped Casa Sollievo Sofferenza, Mol Biol Lab, San Giovanni Rotondo, Italy

[36] Med Univ Lodz, Dept Digest Tract Dis, Lodz, Poland

[37] Inst Hematol & Transfus Med, Warsaw, Poland

[38] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England

[39] Univ & Hosp Trust Verona, ARC NET, Verona, Italy

[40] IRCCS Osped Casa Sollievo Sofferenza, Div Abdominal Surg, San Giovanni Rotondo, Italy

[41] German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany

[42] Natl Ctr Tumor Dis NCT, Heidelberg, Germany

[43] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany

来源：

INTERNATIONAL JOURNAL OF CANCER | 2019年 / 144卷 / 06期

关键词：

pancreatic ductal adenocarcinoma; genetic polymorphisms; lymphocyte telomere length; Mendelian randomization; association; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; POLYMORPHISMS; VARIANTS; DISEASE; LONGER; SURVIVAL; TERT;

D O I：

10.1002/ijc.31928

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Telomere deregulation is a hallmark of cancer. Telomere length measured in lymphocytes (LTL) has been shown to be a risk marker for several cancers. For pancreatic ductal adenocarcinoma (PDAC) consensus is lacking whether risk is associated with long or short telomeres. Mendelian randomization approaches have shown that a score built from SNPs associated with LTL could be used as a robust risk marker. We explored this approach in a large scale study within the PANcreatic Disease ReseArch (PANDoRA) consortium. We analyzed 10 SNPs (ZNF676-rs409627, TERT-rs2736100, CTC1-rs3027234, DHX35-rs6028466, PXK-rs6772228, NAF1-rs7675998, ZNF208-rs8105767, OBFC1-rs9420907, ACYP2-rs11125529 and TERC-rs10936599) alone and combined in a LTL genetic score ("teloscore", which explains 2.2% of the telomere variability) in relation to PDAC risk in 2,374 cases and 4,326 controls. We identified several associations with PDAC risk, among which the strongest were with the TERT-rs2736100 SNP (OR = 1.54; 95%CI 1.35-1.76; p = 1.54 x 10(-10)) and a novel one with the NAF1-rs7675998 SNP (OR = 0.80; 95%CI 0.73-0.88; p = 1.87 x 10(-6), p(trend) = 3.27 x 10(-7)). The association of short LTL, measured by the teloscore, with PDAC risk reached genome-wide significance (p = 2.98 x 10(-9) for highest vs. lowest quintile; p = 1.82 x 10(-10) as a continuous variable). In conclusion, we present a novel genome-wide candidate SNP for PDAC risk (TERT-rs2736100), a completely new signal (NAF1-rs7675998) approaching genome-wide significance and we report a strong association between the teloscore and risk of pancreatic cancer, suggesting that telomeres are a potential risk factor for pancreatic cancer.

引用

页码：1275 / 1283

页数：9

共 50 条

[31] Telomere length, genetic variants and gastroesophageal cancer risk: a case-control study in Chinese population
Du, Jiangbo
Zhu, Xun
Zhu, Chen
Ma, Hongxia
Hu, Zhibin
Shen, Hongbing
Jin, Guangfu
CANCER RESEARCH, 2014, 74 (19)
[32] Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival
Hamada, Tsuyoshi
Yuan, Chen
Bao, Ying
Zhang, Mingfeng
Khalaf, Natalia
Babic, Ana
Morales-Oyarvide, Vicente
Cochrane, Barbara B.
Gaziano, J. Michael
Giovannucci, Edward L.
Kraft, Peter
Manson, JoAnn E.
Ng, Kimmie
Nowak, Jonathan A.
Rohan, Thomas E.
Sesso, Howard D.
Stampfer, Meir J.
Amundadottir, Laufey T.
Fuchs, Charles S.
De Vivo, Immaculata
Ogino, Shuji
Wolpin, Brian M.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (11) : 1868 - 1875
[33] Telomere length determinants in childhood
Gorenjak, Vesna
Petrelis, Alexandros M.
Stathopoulou, Maria G.
Visvikis-Siest, Sophie
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (02) : 162 - 177
[34] A Prospective Study of Relative Telomere Length and Postmenopausal Breast Cancer Risk
De Vivo, Immaculata
Prescott, Jennifer
Wong, Jason Y. Y.
Kraft, Peter
Hankinson, Susan E.
Hunter, David J.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (04) : 1152 - 1156
[35] Short telomere length and breast cancer risk: A study in sister sets
Shen, Jing
Terry, Mary Beth
Gurvich, Irina
Liao, Yuyau
Senie, Ruby T.
Santella, Regina M.
CANCER RESEARCH, 2007, 67 (11) : 5538 - 5544
[36] Telomere Length and Risk of Incident Cancer and Cancer Mortality
Willeit, Peter
Willeit, Johann
Mayr, Agnes
Weger, Siegfried
Oberhollenzer, Friedrich
Brandstaetter, Anita
Kronenberg, Florian
Kiechl, Stefan
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (01): : 69 - 75
[37] Telomere length and cancer risk: finding Goldilocks
Savage, Sharon A.
BIOGERONTOLOGY, 2024, 25 (02) : 265 - 278
[38] Genetic Determinants of Leucocyte Telomere Length in Children: a Neglected and Challenging Field
Stathopoulou, Maria G.
Petrelis, Alexandros M.
Buxton, Jessica L.
Froguel, Philippe
Blakemore, Alexandra I. F.
Visvikis-Siest, Sophie
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2015, 29 (02) : 146 - 150
[39] Telomere length, telomere-related genes, and breast cancer risk: The breast cancer health disparities study
Pellatt, Andrew J.
Wolff, Roger K.
Torres-Mejia, Gabriela
John, Esther M.
Herrick, Jennifer S.
Lundgreen, Abbie
Baumgartner, Kathy B.
Giuliano, Anna R.
Hines, Lisa M.
Fejerman, Laura
Cawthon, Richard
Slattery, Martha L.
GENES CHROMOSOMES & CANCER, 2013, 52 (07): : 595 - 609
[40] Telomere length and cancer risk: finding Goldilocks
Sharon A. Savage
Biogerontology, 2024, 25 : 265 - 278

← 1 2 3 4 5 →